Stock Scorecard



Stock Summary for Cronos Group Inc (CRON) - $2.59 as of 9/17/2025 3:55:45 PM EST

Total Score

17 out of 30

Safety Score

30 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for CRON

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CRON

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CRON

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CRON

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CRON (30 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 6
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CRON

Trump Media's CRO Strategy SPAC Deal Could Redefine Digital Asset Treasuries - ( YORK ) , Trump Media & Tech Gr ( NASDAQ:DJT ) 9/16/2025 11:11:00 AM
Yorkville, Now Trading as $MCGA, Pulls Back the Curtain on Unprecedented Planned Business Combination 9/10/2025 12:30:00 PM
A Closer Look at Altria Group's Options Market Dynamics - Altria Group ( NYSE:MO ) 9/9/2025 8:01:00 PM
What's Going On With Trump Media & Technology Stock Today? - Trump Media & Tech Gr ( NASDAQ:DJT ) 9/9/2025 6:27:00 PM
Trump Media to let Truth Social users convert 'gems' into CRO tokens 9/9/2025 1:57:00 PM
Morning Minute: 📈 Robinhood Makes the S&P 500 While MicroStrategy Gets Skipped 9/8/2025 12:44:00 PM
What Is Trump Media Group CRO Strategy? And Should Investors Get on Board? 9/6/2025 9:15:00 AM
Trump Media closes Crypto.com deal to build $6.4B CRO treasury 9/5/2025 7:54:00 PM
Yorkville Acquisition Corp. Announces Ticker Symbol Change to "MCGA" Ahead of Trump Media Group CRO Strategy, Inc. Listing - Yorkville Acquisition ( NASDAQ:YORK ) , Trump Media & Tech Gr ( NASDAQ:DJT ) 9/5/2025 4:30:00 PM
Yorkville Acquisition Corp. Announces Ticker Symbol Change to "MCGA" Ahead of Trump Media Group CRO Strategy, Inc. Listing 9/5/2025 4:30:00 PM

Financial Details for CRON

Company Overview

Ticker CRON
Company Name Cronos Group Inc
Country USA
Description Cronos Group Inc. is a leading cannabinoid company based in Toronto, Canada, specializing in the production and distribution of innovative cannabis products. With a strong focus on research and development, Cronos leverages its vast expertise to create differentiated offerings in both the medical and recreational cannabis markets. The company is committed to advancing cannabis science and expanding its global presence through strategic partnerships and investments, positioning itself as a key player in the evolving cannabis industry.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - SPECIALTY & GENERIC
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 2.59
Price 4 Years Ago 3.92
Last Day Price Updated 9/17/2025 3:55:45 PM EST
Last Day Volume 1,566,045
Average Daily Volume 3,407,218
52-Week High 2.77
52-Week Low 1.60
Last Price to 52 Week Low 61.88%

Valuation Measures

Trailing PE 51.80
Industry PE 93.51
Sector PE 40.64
5-Year Average PE -9.17
Free Cash Flow Ratio 1.25
Industry Free Cash Flow Ratio 14.85
Sector Free Cash Flow Ratio 29.51
Current Ratio Most Recent Quarter 24.65
Total Cash Per Share 2.07
Book Value Per Share Most Recent Quarter 2.82
Price to Book Ratio 0.90
Industry Price to Book Ratio 12.19
Sector Price to Book Ratio 32.14
Price to Sales Ratio Twelve Trailing Months 7.61
Industry Price to Sales Ratio Twelve Trailing Months 2.89
Sector Price to Sales Ratio Twelve Trailing Months 19.15
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 382,940,000
Market Capitalization 991,814,600
Institutional Ownership 14.70%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 14.40%
Annual Earnings Growth 155.54%
Reported EPS 12 Trailing Months 0.05
Reported EPS Past Year -0.07
Reported EPS Prior Year 0.15
Net Income Twelve Trailing Months 17,834,666
Net Income Past Year 41,080,000
Net Income Prior Year -73,963,000
Quarterly Revenue Growth YOY 20.50%
5-Year Revenue Growth 46.78%
Operating Margin Twelve Trailing Months -13.60%

Balance Sheet

Total Cash Most Recent Quarter 794,416,000
Total Cash Past Year 858,805,000
Total Cash Prior Year 669,291,000
Net Cash Position Most Recent Quarter 794,416,000
Net Cash Position Past Year 858,805,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 1,064,063,000
Total Stockholder Equity Prior Year 1,099,571,000
Total Stockholder Equity Most Recent Quarter 1,082,290,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -9,175,766
Free Cash Flow Per Share Twelve Trailing Months -0.02
Free Cash Flow Past Year 5,689,000
Free Cash Flow Prior Year -46,258,000

Options

Put/Call Ratio 0.36
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.06
MACD Signal 0.08
20-Day Bollinger Lower Band 1.66
20-Day Bollinger Middle Band 2.17
20-Day Bollinger Upper Band 2.68
Beta 1.64
RSI 56.23
50-Day SMA 2.04
150-Day SMA 2.15
200-Day SMA 2.46

System

Modified 9/17/2025 9:20:40 PM EST